The global Disposable Catheters market reached USD 7.3 billion in 2020 and is projected to reach USD 15.0 billion by 2027, growing at a CAGR of 11.8% during the forecast period of 2021-2027. The ...

Background Peripheral venous catheters (PVCs) are ubiquitous in hospitals, yet phlebitis remains common despite ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

CorMedix Therapeutics announced interim results for the company’s ongoing real-world study of its DefenCath (taurolidine ...

A dangerous superbug known as Candida auris has emerged as a growing concern in Texas as cases climb nationwide, particularly ...

The Pitt season premiere, "7:00 a.m.," ignores clichés in favor of a gritty, realistic, and uncompromising take on the ...

CorMedix is a promising biopharma firm in the catheter lock solution space. Continued success for its top products could fuel ...

The Trump administration just yanked the recommendation for a vaccine that can spare people from what I went through.

CorMedix Therapeutics is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases.

I’ve been the doctor responding to medical emergencies on a flight, and the medical kits I used contained minimal supplies.

Under the leadership of Mr. Todisco, CorMedix has evolved from a single product, development stage company into a multi-product, diversified commercial operation with positive cashflow and a strong ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...